有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-2-(3-bromopyridin-2-yl)sulfanyl-N-(2-cyanoethyl)-N-methylpropanamide | —— | C12H14BrN3OS |
|
—— | 2-(3-bromopyridin-2-yl)sulfanyl-N-[(2S)-2-cyano-3-methylbutan-2-yl]acetamide | —— | C13H16BrN3OS |
|
—— | (2S)-2-(3-bromopyridin-2-yl)sulfanyl-N-propan-2-ylpropanamide | —— | C11H15BrN2OS |
|
—— | 2-(3-bromopyridin-2-yl)sulfanyl-N-[(2R)-2-cyano-3-methylbutan-2-yl]acetamide | —— | C13H16BrN3OS |
|
—— | (2R)-2-(3-bromopyridin-2-yl)sulfanyl-N-cyclopropylpropanamide | —— | C11H13BrN2OS |
|
—— | (2R)-2-(3-bromopyridin-2-yl)sulfanyl-1-pyrrolidin-1-ylpropan-1-one | —— | C12H15BrN2OS |
|
—— | 2-[[(2R)-oxolan-2-yl]methylsulfanyl]-4-(trifluoromethyl)-1H-pyrimidin-6-one | —— | C10H11F3N2O2S |
|
—— | 2-(3-bromopyridin-2-yl)sulfanyl-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C12H15BrN2O2S |
|
—— | (2S)-2-(3-bromopyridin-2-yl)sulfanyl-N-cyclopropylpropanamide | —— | C11H13BrN2OS |
|
—— | (2S)-2-(3-bromopyridin-2-yl)sulfanyl-1-pyrrolidin-1-ylpropan-1-one | —— | C12H15BrN2OS |
|
—— | (2R)-2-(3-bromopyridin-2-yl)sulfanyl-N-(3-ethoxypropyl)propanamide | —— | C13H19BrN2O2S |
|
—— | (2S)-2-(3-bromopyridin-2-yl)sulfanyl-N-(3-methoxypropyl)propanamide | —— | C12H17BrN2O2S |
|
—— | 2-(3-bromopyridin-2-yl)sulfanyl-1-[(2R,6R)-2,6-dimethylmorpholin-4-yl]ethanone | —— | C13H17BrN2O2S |
|
—— | (2R)-2-(3-bromopyridin-2-yl)sulfanyl-N-propan-2-ylpropanamide | —— | C11H15BrN2OS |
|
—— | 2-[(1S)-1-(3-bromopyridin-2-yl)sulfanylethyl]-5-(2-methylpropyl)-1,3,4-oxadiazole | —— | C13H16BrN3OS |
|
—— | (2S)-2-(3-bromopyridin-2-yl)sulfanyl-N-(3-ethoxypropyl)propanamide | —— | C13H19BrN2O2S |
|
—— | 2-(3-bromopyridin-2-yl)sulfanyl-1-[(2S,6S)-2,6-dimethylmorpholin-4-yl]ethanone | —— | C13H17BrN2O2S |
|
—— | 2-[(1R)-1-(3-bromopyridin-2-yl)sulfanylethyl]-5-(2-methylpropyl)-1,3,4-oxadiazole | —— | C13H16BrN3OS |
|
—— | (2R)-2-(3-bromopyridin-2-yl)sulfanyl-N-(2-cyanoethyl)-N-methylpropanamide | —— | C12H14BrN3OS |
|
—— | 2-[[(2S)-oxolan-2-yl]methylsulfanyl]-4-(trifluoromethyl)-1H-pyrimidin-6-one | —— | C10H11F3N2O2S |
|
—— | 2-(3-bromopyridin-2-yl)sulfanyl-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C12H15BrN2O2S |
|
—— | (2R)-2-(3-bromopyridin-2-yl)sulfanyl-N-(3-methoxypropyl)propanamide | —— | C12H17BrN2O2S |
|
—— | 5-amino-1-[(3S)-2,3-dihydro-1-benzothiophene-3-carbonyl]pyrazole-4-carbonitrile | —— | C13H10N4OS |
|
—— | 5-amino-1-[(3R)-2,3-dihydro-1-benzothiophene-3-carbonyl]pyrazole-4-carbonitrile | —— | C13H10N4OS |
|
—— | (3S)-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C18H26N2O2S |
|
—— | 1-[4-[(3S)-2,3-dihydro-1-benzothiophene-3-carbonyl]-1,4-diazepan-1-yl]ethanone | —— | C16H20N2O2S |
|
—— | (3S)-N-[(2R)-1-(2,2,2-trifluoroethoxy)propan-2-yl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C14H16F3NO2S |
|
—— | (3R)-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C18H26N2O2S |
|
—— | 1-[4-[(3R)-2,3-dihydro-1-benzothiophene-3-carbonyl]-1,4-diazepan-1-yl]ethanone | —— | C16H20N2O2S |
|
—— | (3R)-N-[(2R)-1-(2,2,2-trifluoroethoxy)propan-2-yl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C14H16F3NO2S |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-(3,4-difluorophenyl)sulfanylpropanamide | —— | C16H18F2N2OS |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-(3,4-difluorophenyl)sulfanylpropanamide | —— | C16H18F2N2OS |
|
—— | (3R)-N-[(2S)-1-(2,2,2-trifluoroethoxy)propan-2-yl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C14H16F3NO2S |
|
—— | (3S)-N-[(2S)-1-(2,2,2-trifluoroethoxy)propan-2-yl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C14H16F3NO2S |
|
—— | (3S)-3-[(5-ethyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C11H15F3N4OS |
|
—— | 1-ethyl-2-[(3R)-2-oxo-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]sulfanylpyrimidin-4-one | —— | C12H14F3N3O2S |
|
—— | 1-ethyl-2-[(3S)-2-oxo-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]sulfanylpyrimidin-4-one | —— | C12H14F3N3O2S |
|
—— | (3R)-3-[(5-ethyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C11H15F3N4OS |
|
—— | 3-(dicyclopentylmethyl)-1-methyl-1-[(2R)-1-methylsulfonylpropan-2-yl]urea | —— | C17H32N2O3S |
|
—— | 1-[2-(4-Methylphenyl)sulfanylethyl]-3-(3-morpholin-4-ylpropyl)thiourea | —— | C17H27N3OS2 |
|
—— | 4-formyl-N-(2-phenylsulfanylethyl)piperazine-1-carbothioamide | —— | C14H19N3OS2 |
|
—— | (3S)-3-(1,3-dioxolan-2-yl)-1-(2-phenylsulfanylethyl)piperidine | —— | C16H23NO2S |
|
—— | 1-[(3S)-1-methylpiperidin-3-yl]-4-(2-phenylsulfanylethyl)piperazine | —— | C18H29N3S |
|
—— | 3-(dicyclopentylmethyl)-1-methyl-1-[(2S)-1-methylsulfonylpropan-2-yl]urea | —— | C17H32N2O3S |
|
—— | 1-[2-(4-Methylphenyl)sulfanylethyl]-3-(3-methylsulfanylpropyl)thiourea | —— | C14H22N2S3 |
|
—— | 1-[(3R)-1-methylpiperidin-3-yl]-4-(2-phenylsulfanylethyl)piperazine | —— | C18H29N3S |
|
—— | 2-[[4-cyclopropyl-5-[(3R)-piperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]pyrimidine | —— | C14H18N6S |
|
—— | 1-[2-(4-methylphenyl)sulfanylethyl]-3-[[(2R)-oxolan-2-yl]methyl]thiourea | —— | C15H22N2OS2 |
|
—— | 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-1-[(2R)-2-(5-ethylfuran-2-yl)pyrrolidin-1-yl]ethanone | —— | C18H23N3O2S |
|
—— | 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-1-[(2S)-2-(5-ethylfuran-2-yl)pyrrolidin-1-yl]ethanone | —— | C18H23N3O2S |
|